Comparing effects of soybean oil- and palm olein-based mayonnaise consumption on the plasma lipid and lipoprotein profiles in human subjects: A double-blind randomized controlled trial with cross-over design

Lipids in Health and Disease

Volumn 15, Issue 1, 2016, Pages

  Karupaiah, Tilakavati ^a   Chuah, Khun Aik ^a   Chinna, Karuthan ^b   Matsuoka, Ryosuke ^c   Masuda, Yasunobu ^c   Sundram, Kalyana ^d   Sugano, Michihiro ^e  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c KEWPIE CORPORATION   (Japan)

^d Malaysian Palm Oil Council   (Malaysia)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

Cardiometabolic risk; Fatty acids; Lipids; Lipoprotein particles; Mayonnaise

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PALM OIL; PALM OLEIN; SOYBEAN OIL; UNCLASSIFIED DRUG; CHOLESTEROL; EDIBLE OIL; LINOLEIC ACID; LIPID; LIPOPROTEIN; OLEIC ACID; TRIACYLGLYCEROL; VEGETABLE OIL;

ADULT; ARTICLE; BODY WEIGHT; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; FOOD; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; MALE; MAYONNAISE; MONITORING; NORMAL HUMAN; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; BLOOD; COMPARATIVE STUDY; DIET; YOUNG ADULT;

ADOLESCENT; ADULT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIET; DIETARY FATS, UNSATURATED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LINOLEIC ACID; LIPIDS; LIPOPROTEINS; MALE; OLEIC ACID; PLANT OILS; SOYBEAN OIL; TRIGLYCERIDES; YOUNG ADULT;

EID: 84982110276     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-016-0301-9     Document Type: Article

References (51)

1. United States Department of Agriculture. Dietary Guidelines for Americans. 2015, USDA-Department of Health and Human Sciences http://www.health.gov/dietaryguidelines/2015-scientific-report. Accessed 1 Aug 2015.
2. Shin JY, Xun PC, Nakamura Y, He K. Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2013;98:146-59.
3. Eckel RH, Jakicic JM, Ard JD, Miller NH, Hubbard VS, Nonas CA, et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2960-84.
4. Harika RK, Eilander A, Alssema M, Osendarp SJ, Zock PL. Intake of fatty acids in general populations worldwide does not meet dietary recommendations to prevent coronary heart disease: a systematic review of data from 40 countries. Ann Nutr Metab. 2013;63:229-38.
5. Scicchitano P, Cameli M, Maiello M, Amedeo P, Myiesan ML, Novo S, Palmiero P, Saba PS, Pedrinelli R, Ciccone MM. Neurraceuticals and dyslipidemia: beyond the common therapeutics. J Func Foods. 2014;6:11-32.
6. Micha R, Khatibzadeh S, Shi P, Fahimi S, Lim S, Andrews KG, Engell RE, Powles J, Ezzati M, Mozaffarian D, et al. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ. 2014;348:g2272.
7. Wang DD, Li Y, Chiuve SE, Stampfer MJ, Manson JE, Rimm EB, Willet WC & Hu FB. Association of specific dietary fats with total and cause-specific mortality. JAMA Intern Med. 2016. doi: 10.1001/jamainternmed.2016.2417.
8. Indahl UG, Sahni NS, Kirkhus B, Næs T. Multivariate strategies for classification based on NIR-spectra - with application to mayonnaise. Chemom Intell Lab Syst. 1999;49:19-31.
9. Ma Z, Boye JI. Advances in the design and production of reduced-fat and reduced-cholesterol salad dressing and mayonnaise: a review. Food Bioprocess Technol. 2013;6:648-70.
10. Newkirk DR, Sheppard AJ, Hubbard WD. Comparison of total fat, fatty acids, cholesterol, and other sterols in mayonnaise and imitation mayonnaise. J Am Oil Chem Soc. 1978;55:A548-9.
11. Karupaiah T, Noor MI, Sundram K. Dietary fatty acids and their influence on blood lipids and lipoproteins. In: Akoh CC, Lai O-M, editors. "Healthful Lipids" Champaign. Illinois: AOCS Press; 2005. p. 171-203.
12. Amini M, Esmaillzadeh A, Shafaeizadeh S, Behrooz J, Zare M. Relationship between major dietary patterns and metabolic syndrome among individuals with impaired glucose tolerance. Nutrition. 2010;26:986-92.
13. Akter S, Nanri A, Pham NM, Kurotani K, Mizoue T. Dietary patterns and metabolic syndrome in a Japanese working population. Nutr & Metab. 2013;10:30.
14. Hanson GK. Inflammation, atherosclerosis and coronary artery disease. New Eng J Med. 2005;352:1658-95.
15. Esposito K, Giugliano D. Diet and inflammation: a link to metabolic and cardiovascular diseases. Eur Heart J. 2006;27:15-20.
16. Mozaffarian D, Appel LJ, Van Horn L. Components of a cardioprotective diet- new insights. Circulation. 2011;123:2870-91.
17. Karupaiah T, Sundram K. Modulation of human postprandial lipemia by changing ratios of polyunsaturated to saturated (P/S) content of blended dietary fats: a cross-over design with repeated measures. Nutrition J. 2013;12:122.
18. Sundram K, Karupaiah T, Hayes C. Stearic acid-rich interesterified fat and trans-rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humans. Nutr & Metab. 2007;4:3.
19. Karupaiah T, Tan CH, Chinna K, Sundram K. The chain length of dietary saturated fatty acids affects human postprandial lipemia. J Am Coll Nutr. 2011;30:511-21.
20. DataBank F. Nutritionist Pro™-Nutritional analysis software. Stafford: Axxya Systems Licensee-, Hearst Corporation; 2005.
21. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-5.
22. Nägele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22:165-74.
23. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem. 1982;28:1379-88.
24. Friedewald WT, Levy RI, Frederickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
25. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1969;6:24.
26. Shimizu S, Yasui K, Tani Y, Yamada H. Acyl-CoA oxidase from candida troticalis. Biochem Biophys Res Commun. 1979;91:108-13.
27. Walldius G, Jungner I. Apolipoprotein B and A-1: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med. 2004;255:188-255.
28. Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods in Molecular Biol. 1998;108:101-6.
29. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New Eng J Med. 2004;350:1387-97.
30. Otvos JD. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab. 2002;48:171-80.
31. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res. 1985;26:194-202.
32. Baum SJ, Kris-Etherton PM, Willett WC, Lichtenstein AH, Rudel LL, Maki KC, et al. Fatty acids in cardiovascular health and disease: a comprehensive update. J Clin Lipidol. 2012;6:216-34.
33. Kris-Etherton PM, Fleming JA. Emerging nutrition science on fatty acids and cardiovascular disease: nutritionists' perspectives. Advan in Nutr. 2015;6:326S-37.
34. Medical Research Council. Controlled trial of soya-bean oil in myocardial infarction. Lancet. 1968;2:693-9.
35. Miettinen M, Huttunen JK, Naukkarinen V, Strandberg T, Mattila S, Kumlin T, Sarna S. Multifactorial primary prevention of cardiovascular diseases in middle aged men. Risk factor changes, incidence, and mortality. JAMA. 1985;254:2097-102.
36. Miettinen M, Turpeinen O, Karvonen MJ, Pekkarinen M, Paavilainen E, Elosuo R. Dietary prevention of coronary heart disease in women: the Finnish mental hospital study. Int J Epidmiol. 1983;12:17-25.
37. Watts GF, Jackson P, Mandalia S, Brunt JN, Lewis ES, Coltart DJ, Lewis B. Nutrient intake and progression of coronary artery disease. Am J Cardiol. 1994;73:328-32.
38. Ma J, Folsom AR, Lewis L, Eckfeldt JH. Relation of plasma phospholipid and cholesterol ester fatty acid composition to carotid artery intima-media thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 1997;65:551-9.
39. Ng TKW, Hayes KC, DeWitt GF, Jegathesan M, Satgunasingam N, Ong A, et al. Dietary palmitic and oleic acids exert similar effects on serum cholesterol and lipoprotein profiles in normocholesterolemic men and women. J Am Coll Nutr. 1992;11:383-90.
40. Choudhury N, Tan L, Truswell AS. Comparison of palm olein and olive oil: effects on plasma lipids and vitamin E in young adults. Am J Clin Nutr. 1995;61:1043-51.
41. Young SG. Recent progress in understanding apolipoprotein B. Circulation. 1990;82:1574-94.
42. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002;43:1363-79.
43. Cromwell WC, Otvos JD. Low-density lipoprotein particle number and risk for cardiovascular disease. Curr Atheroscler Rep. 2004;6:381-7.
44. Knopp RH, Retzlaff BM, Walden CE, Dowdy AA, Tsunehara CH, Austin MA, Nguyen T. A double-blind, randomized, controlled trial of the effects of two eggs per day in moderately hypercholesterolemic and combined hyperlipidemic subjects taught the NCEP step I diet. J Am Coll Nutr. 1997;16:551-61.
45. Herron KL, Lofgren IE, Sharman M, Volek JS, Fernandez ML. High intake of cholesterol results in less atherogenic low-density lipoprotein particles in men and women independent of response classification. Metabolism. 2004;53:823-30.
46. Fritsche KL. The science of fatty acids and inflammation. Advan in Nutr. 2015;6:293S-301.
47. Rett BS, Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review. Nutr & Metab. 2011;8:36.
48. Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr. 2004;79:969-73.
49. Donovan SM, Shamir R. Introduction to the yoghurt in nutrition initiative and the first global summit on the health effects of yoghurt. Am J Clin Nutr. 2014;99:1209-11.
50. Cusack LK, Fernandez ML, Volek JS. The food matrix and sterol characteristics affect the plasma cholesterol lowering of phytosterol/phytostanol. Advan in Nutr. 2013;4:633-43.
51. Saito S, Takeshita M, Tomonobu K, Kudo N, Shiiba D, Hase T, et al. Dose-dependent cholesterol-lowering effect of a mayonnaise-type product with a main component of diacylglycerol-containing plant sterol esters. Nutrition. 2006;22:174-8.